Insider · CIK 0001791108
Emily Gottschalk
Files at ANIX (Anixa Biosciences Inc). First filing -, latest -.
Emily Gottschalk files SEC Form 4 as director at ANIX (Anixa Biosciences Inc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Emily Gottschalk has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | ANIX Anixa Biosciences Inc | AGrant or award Employee Stock Optionderivative | +25,000 | $0.00 | $0 | 25,000 | Jan 6, 2026 |
| Jan 2, 2025 | ANIX Anixa Biosciences Inc | AGrant or award Employee Stock Optionderivative | +25,000 | $0.00 | $0 | 25,000 | Jan 3, 2025 |
Questions about Emily Gottschalk
Answered from the filings on this page, as of the latest one.
Is Emily Gottschalk buying or selling?
Emily Gottschalk has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Emily Gottschalk's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Emily Gottschalk has 0.
Where does Emily Gottschalk file Form 4?
Emily Gottschalk has filed Form 4 at ANIX (Anixa Biosciences Inc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.